Visiting Dana-Farber? See our prescreening and mask requirements.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Studies lead to innovation Collaborative research and care among specialists with vast expertise in the management of histiocyte diseases have the strong potential to result in better outcomes for patients. Collaborations tend to yield: More effective treatment strategies Better management of side effects Minimization of those side effects
Collaborative research and care among specialists with vast expertise in the management of histiocyte diseases have the strong potential to result in better outcomes for patients. Collaborations tend to yield:
In a field whose research has been fragmented in the past, the Adult Histiocyte Disorders Center has led the effort to unite leading national and international organizations in collaborative research:
As world leaders in clinical trials for adult histiocyte disorders, we have several studies in progress, including:
At our Center, we are searching for an inherited tendency towards these diseases. Using our advanced gene sequencing platform, OncoPanel, we conduct, without charge, genetic profiling of the disease for every patient for whom tissue is available.
We are also collaborating with Baylor University/Texas Children's Hospital in a study of genetic links in histiocyte disorders.
Dr. Eric Jacobsen on Rosia-Dorfman disease treatment and researchIn this video, Eric Jacobsen, MD, explains Rosai-Dorfman, a rare form of histiocytosis. He discusses recent research identifying important mutations present in this disease that may be treated with targeted therapy. These findings offer hope to patients with this condition and may lead to further treatment advances.
New Patient Appointments 877-442-3324
Clinical Trials Questions?
877-DF-TRIAL (877-338-7425)